Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus

A vaccine regimen that elicits broadly neutralizing antibodies (bNAbs) is a major goal in HIV-1 vaccine research. In this study, we assessed the immunogenicity of the CAP256 superinfecting viral envelope (CAP256 SU) protein delivered by modified vaccinia virus Ankara (MVA) and DNA vaccines in differ...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Virol
Главные авторы: van Diepen, Michiel T., Chapman, Rosamund, Douglass, Nicola, Galant, Shireen, Moore, Penny L., Margolin, Emmanuel, Ximba, Phindile, Morris, Lynn, Rybicki, Edward P., Williamson, Anna-Lise
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2019
Предметы:
Vaccines and Antiviral Agents
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6450106/
https://ncbi.nlm.nih.gov/pubmed/30760570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02155-18
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы